124 related articles for article (PubMed ID: 11984074)
1. Synthesis of a novel phosphatidylcholine conjugated to docosahexaenoic acid and methotrexate that inhibits cell proliferation.
Zerouga M; Stillwell W; Jenski LJ
Anticancer Drugs; 2002 Mar; 13(3):301-11. PubMed ID: 11984074
[TBL] [Abstract][Full Text] [Related]
2. A novel phosphatidylcholine which contains pentadecanoic acid at sn-1 and docosahexaenoic acid at sn-2 in Schizochytrium sp. F26-b.
Abe E; Hayashi Y; Hama Y; Hayashi M; Inagaki M; Ito M
J Biochem; 2006 Aug; 140(2):247-53. PubMed ID: 16829536
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid class as a determinant in docosahexaenoic acid's effect on tumor cell viability.
Zerouga M; Stillwell W; Stone J; Powner A; Jenski LJ
Anticancer Res; 1996; 16(5A):2863-8. PubMed ID: 8917399
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of docosahexaenoic acid-containing phospholipids on 5-lipoxygenase in rat basophilic leukemia cells.
Matsumoto K; Morita I; Hibino H; Murota S
Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):861-6. PubMed ID: 8302921
[TBL] [Abstract][Full Text] [Related]
5. Comparison of phosphatidylcholines containing one or two docosahexaenoic acyl chains on properties of phospholipid monolayers and bilayers.
Zerouga M; Jenski LJ; Stillwell W
Biochim Biophys Acta; 1995 Jun; 1236(2):266-72. PubMed ID: 7794965
[TBL] [Abstract][Full Text] [Related]
6. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid in phosphatidylcholine mediates cytotoxicity more effectively than other omega-3 and omega-6 fatty acids.
Kafrawy O; Zerouga M; Stillwell W; Jenski LJ
Cancer Lett; 1998 Oct; 132(1-2):23-9. PubMed ID: 10397449
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid increases permeability of lipid vesicles and tumor cells.
Stillwell W; Ehringer W; Jenski LJ
Lipids; 1993 Feb; 28(2):103-8. PubMed ID: 8441334
[TBL] [Abstract][Full Text] [Related]
9. Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma.
Alekseeva AA; Moiseeva EV; Onishchenko NR; Boldyrev IA; Singin AS; Budko AP; Shprakh ZS; Molotkovsky JG; Vodovozova EL
Int J Nanomedicine; 2017; 12():3735-3749. PubMed ID: 28553111
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid-containing phosphatidylethanolamine in the external layer of liposomes protects docosahexaenoic acid from 2,2'-azobis(2-aminopropane)dihydrochloride-mediated lipid peroxidation.
Kubo K; Sekine S; Saito M
Arch Biochem Biophys; 2003 Feb; 410(1):141-8. PubMed ID: 12559986
[TBL] [Abstract][Full Text] [Related]
11. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
[TBL] [Abstract][Full Text] [Related]
13. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
Kaasgaard T; Andresen TL; Jensen SS; Holte RO; Jensen LT; Jørgensen K
Chem Phys Lipids; 2009 Feb; 157(2):94-103. PubMed ID: 19094974
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Identification of AceDoxyPC, a Protectin-Containing Structured Phospholipid, Using Liquid Chromatography/Mass Spectrometry.
Lo Van A; Fourmaux B; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
Lipids; 2017 Sep; 52(9):751-761. PubMed ID: 28776175
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acid-containing liposomes in cancer therapy.
Jenski LJ; Zerouga M; Stillwell W
Proc Soc Exp Biol Med; 1995 Dec; 210(3):227-33. PubMed ID: 8539260
[TBL] [Abstract][Full Text] [Related]
16. Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1.
Shikano M; Masuzawa Y; Yazawa K
J Immunol; 1993 Apr; 150(8 Pt 1):3525-33. PubMed ID: 8468486
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats.
Atkinson TG; Barker HJ; Meckling-Gill KA
Lipids; 1997 Mar; 32(3):293-302. PubMed ID: 9076666
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of histone deacetylase activity is a novel function of the antifolate drug methotrexate.
Yang PM; Lin JH; Huang WY; Lin YC; Yeh SH; Chen CC
Biochem Biophys Res Commun; 2010 Jan; 391(3):1396-9. PubMed ID: 20026300
[TBL] [Abstract][Full Text] [Related]
19. Free radical oxidation of plasmalogen glycerophosphocholine containing esterified docosahexaenoic acid: structure determination by mass spectrometry.
Zemski Berry KA; Murphy RC
Antioxid Redox Signal; 2005; 7(1-2):157-69. PubMed ID: 15650405
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of triacylglycerols containing ricinoleate in castor microsomes using 1-acyl-2-oleoyl-sn-glycero-3-phosphocholine as the substrate of oleoyl-12-hydroxylase.
Lin JT; Woodruff CL; Lagouche OJ; McKeon TA; Stafford AE; Goodrich-Tanrikulu M; Singleton JA; Haney CA
Lipids; 1998 Jan; 33(1):59-69. PubMed ID: 9470174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
